[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE9003222L - PREPARATION FOR PROPHYLACTIC, THERAPEUTIC AND DIAGNOSTIC USE FOR INFECTIONS - Google Patents

PREPARATION FOR PROPHYLACTIC, THERAPEUTIC AND DIAGNOSTIC USE FOR INFECTIONS

Info

Publication number
SE9003222L
SE9003222L SE9003222A SE9003222A SE9003222L SE 9003222 L SE9003222 L SE 9003222L SE 9003222 A SE9003222 A SE 9003222A SE 9003222 A SE9003222 A SE 9003222A SE 9003222 L SE9003222 L SE 9003222L
Authority
SE
Sweden
Prior art keywords
group
prophylactic
infections
therapeutic
preparation
Prior art date
Application number
SE9003222A
Other languages
Swedish (sv)
Other versions
SE9003222D0 (en
Inventor
Jens Sandros
Nicklas Stroemberg
Original Assignee
Jens Sandros
Nicklas Stroemberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jens Sandros, Nicklas Stroemberg filed Critical Jens Sandros
Priority to SE9003222A priority Critical patent/SE9003222L/en
Publication of SE9003222D0 publication Critical patent/SE9003222D0/en
Priority to CA002046211A priority patent/CA2046211A1/en
Priority to EP91918192A priority patent/EP0552233A1/en
Priority to AU87223/91A priority patent/AU8722391A/en
Priority to PCT/SE1991/000662 priority patent/WO1992006692A1/en
Publication of SE9003222L publication Critical patent/SE9003222L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A composition for prophylactic, therapeutic treatment and/or diagnosis in connection with infections, which as an active constituent contains a compound having structural formula (I) wherein R1 comprises the structure (II) and R2 is chosen from the following group of substituents: acetamide group, propyl, butyl and lower acyl group or another group and R3 and R4, R5, R6, R7 and R8 are the same or different and are hydrogen or an organic group, e.g. lower alkyl-, lower acyl- or a carbohydrate group or an inorganic group such as sulphate or phosphate.
SE9003222A 1990-10-10 1990-10-10 PREPARATION FOR PROPHYLACTIC, THERAPEUTIC AND DIAGNOSTIC USE FOR INFECTIONS SE9003222L (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9003222A SE9003222L (en) 1990-10-10 1990-10-10 PREPARATION FOR PROPHYLACTIC, THERAPEUTIC AND DIAGNOSTIC USE FOR INFECTIONS
CA002046211A CA2046211A1 (en) 1990-10-10 1991-07-04 Composition for therapeutic, prophylactic or diagnostic use in connection with infections
EP91918192A EP0552233A1 (en) 1990-10-10 1991-10-03 Composition for therapeutic, prophylactic or diagnostic use in connection with infections
AU87223/91A AU8722391A (en) 1990-10-10 1991-10-03 Composition for therapeutic, prophylactic or diagnostic use in connection with infections
PCT/SE1991/000662 WO1992006692A1 (en) 1990-10-10 1991-10-03 Composition for therapeutic, prophylactic or diagnostic use in connection with infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003222A SE9003222L (en) 1990-10-10 1990-10-10 PREPARATION FOR PROPHYLACTIC, THERAPEUTIC AND DIAGNOSTIC USE FOR INFECTIONS

Publications (2)

Publication Number Publication Date
SE9003222D0 SE9003222D0 (en) 1990-10-10
SE9003222L true SE9003222L (en) 1992-04-11

Family

ID=20380598

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003222A SE9003222L (en) 1990-10-10 1990-10-10 PREPARATION FOR PROPHYLACTIC, THERAPEUTIC AND DIAGNOSTIC USE FOR INFECTIONS

Country Status (5)

Country Link
EP (1) EP0552233A1 (en)
AU (1) AU8722391A (en)
CA (1) CA2046211A1 (en)
SE (1) SE9003222L (en)
WO (1) WO1992006692A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8001748L (en) * 1980-03-05 1981-09-06 Kaellenius Gunilla COMPOSITIONS FOR THERAPEUTICAL OR DIAGNOSTIC APPLICATION AS PROCEDURES FOR THERAPEUTICS
EP0089940A1 (en) * 1982-03-23 1983-09-28 BioCarp AB Compositions for therapeutic or diagnostic use containing oligosaccharides
SE8304007D0 (en) * 1983-07-15 1983-07-15 Karlsson Karl Anders ASSOCIATION AND COMPOSITION OF THERAPEUTIC OR DIAGNOSTIC USE AND PROCEDURE FOR THERAPEUTIC TREATMENT
EP0380084A3 (en) * 1989-01-27 1991-03-13 The Biomembrane Institute Method for the inhibition of cell-cell and cell substratum interactions by the blocking of carbohydrate-carbohydrate interactions

Also Published As

Publication number Publication date
WO1992006692A1 (en) 1992-04-30
EP0552233A1 (en) 1993-07-28
SE9003222D0 (en) 1990-10-10
AU8722391A (en) 1992-05-20
CA2046211A1 (en) 1992-04-11

Similar Documents

Publication Publication Date Title
ES2098004T3 (en) PEPTIDES DERIVED FROM TRIFLUORO-METHYL-KETONES WITH AN INHIBITING ACTIVITY OF HUMAN LEUKOCITARY ELASTASE (HLE), ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
AR023807A1 (en) AN AGENT TO TREAT DRY EYE AND USE A MACROLID COMPOUND TO PREPARE PHARMACEUTICAL COMPOSITIONS FOR DRY EYE TREATMENT
FI911286A0 (en) CHEMICAL FOERENINGAR.
ES2108129T3 (en) NEW DERIVATIVES OF PIRAZINE, ITS PREPARATION AND USE.
DE69024778D1 (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their therapeutic use
EA199900135A1 (en) DERIVATIVES OF PYRAZOLOPIRIDINE AND THEIR APPLICATION AS A PHARMACEUTICAL PREPARATION
DE3879258D1 (en) PREPARATION AGAINST ULCUS.
FI812804L (en) 2- (1,4-BENZODIOXAN-2-YLALKYL) -IMIDAZOLER ANVAENDBARA SOM ANTIDEPRESSIVE CEILING MODEL
DK624989A (en) macrolide
SE9003222D0 (en) PREPARATION FOR PROPHYLACTIC, THERAPEUTIC AND DIAGNOSTIC USE FOR INFECTIONS
AR007052A1 (en) A CARBOHYDRATE DERIVATIVE, ITS USE AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
DK0891346T3 (en) Dihydrobenzofuran compounds useful as anti-inflammatory agents
BR0013694A (en) Compound, process for preparing a compound, pharmaceutical composition, and use of a compound
DK0738712T3 (en) Substituted indenoylguanidines with antiarrhythmic cardioprotective effect
ES2078911T3 (en) PHENYL-HETEROCICLES DISSTITUTED IN 3.4 AND ITS USE.
ES2080336T3 (en) DERIVATIVES OF METHYLPIPERAZINOAZEPINE, ITS PREPARATION AND ITS USE.
ES2095431T3 (en) N- (ISOQUINOLEIN-5-IL) -SULFONIL-AZACICLOALCANOS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ATE5480T1 (en) THIAZOLO(3,2-A)PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE DERIVATIVES.
ES2058097T3 (en) ANTIBACTERIAL AGENT FOR USE IN MAMMALS AND INCLUDING CEPHALOSPORIN DERIVATIVES AS AN ACTIVE INGREDIENT.
ATE77822T1 (en) 13ALPHA ALKYLGONANE DELTA9(11)-5,10-EPOXIDES.
SE9201188L (en) New use
MX9102181A (en) IMINOBENZODIAZEPINE FOR THE TREATMENT OF SLEEP DISORDERS
FI921475A0 (en) 1,4-DIHYDRO-4-OXO-3-QUINOL DERIVATIVES WITH SELECTIVE TOXIC ANTIBACTERIA AEMENN HOS DAEGGDJUR.
TH13535EX (en) "New compound"
DE69104646D1 (en) 2-Fluorneplanocin A and its preparation.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9003222-8

Effective date: 19940501